Olux-E FDA Approval History
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
Development Timeline for Olux-E
|Jan 12, 2007||Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.